pSivida is engaged in developing tiny, sustained-release drug delivery products created to deliver drugs at a controlled or steady rate for months or years. The company is currently focused on treating chronic diseases of the back of the eye utilizing … Continue reading →

Sucampo Pharmaceuticals is a worldwide pharmaceutical company engaged in the innovative research, discovery, development and commercialization of proprietary drugs based on prostones. Sucampo Chairman, CEO and Co-founder Ryuji Ueno, M.D., Ph.D., was the first person to identify the therapeutic potential … Continue reading →

Regulus Therapeutics is a biopharmaceutical company at the forefront of discovering and developing innovative medicines that target microRNAs. Leveraging a mature therapeutic platform that is based on technology developed over 20 years, the company is advancing microRNA therapeutics toward clinical … Continue reading →

Protalix BioTherapeutics is a biopharmaceutical company engaged in developing and commercializing recombinant therapeutic proteins expressed through ProCellEx, a proprietary plant cell-based expression system. Using ProCellEx, the company is developing and commercializing a proprietary pipeline of novel and biosimilar proteins that … Continue reading →

Astex Pharmaceuticals is a pharmaceutical company focused on the discovery and development of novel small molecule therapeutics, with a focus on oncology. The company is currently engaged in developing a proprietary pipeline of novel therapies and is creating de-risked products … Continue reading →

NanoViricides is a development-stage company engaged in creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide class of drug candidates is designed for the specific purpose of attacking and dismantling enveloped virus particles. NanoViricides is developing drugs against … Continue reading →

Prima BioMed is a biotechnology that is active throughout the world. A leader in personalized bio-therapeutic cancer products, the company is focused on leveraging its current technology and expertise in developing innovative treatment options for patients as well as maximizing … Continue reading →

Synthetic Biologics is a biotechnology company developing product candidates for serious infections and diseases. The company is developing a biologic for preventing C. diff infection as well as a series of monoclonal antibodies (mAbs) for treating serious infectious diseases. In … Continue reading →